In vitro and in vivo evaluation of cerium oxide nanoparticles in respiratory syncytial virus infection.
Bioact Mater
; 24: 124-135, 2023 Jun.
Article
en En
| MEDLINE
| ID: mdl-36606255
APTES, 3-aminopropyltriethoxysilane; BAL, Bronchoalveolar lavage; BHA, Butylated hydroxyanisole; Bioactive nanoparticles; CNP, Cerium oxide nanoparticles; Cerium oxide nanoparticles; DLS, Dynamic light scattering; DMEM, Dulbecco's Modified Eagle's Medium; FITC, Fluorescein isothiocyanate; Gas6, Growth arrest specific-6; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; Immunomodulation; MFI, Mean fluorescence intensity; Macrophage phenotypes; Nanoparticle shape; PBS, Phosphate buffered saline; RFU, Relative fluorescence units; RNS, Reactive nitrogen species; ROS, Reactive oxygen species; RSV, Respiratory syncytial virus; Reactive oxygen species; Respiratory syncytial virus; SDS-PAGE, Sodium dodecyl sulfate polyacrylamide gel electrophoresis; SOD, Superoxide dismutase; TEM, Transmission electron microscopy; iNOS, Induced nitrous oxide synthase
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Bioact Mater
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
China